Biosimilar Entry Under Biologics Price Competition & Innovation Act Topic of White Paper From CRS
June 18, 2025
June 18, 2025
WASHINGTON, June 18 (TNSLrpt) -- The Congressional Research Service issued the following In Focus white paper (No. IF13029) on June 12, 2025, by legislative attorney Kevin J. Hickey.
Here are excerpts:
* * *
Pharmaceutical Patent Disputes: Biosimilar Entry Under the Biologics Price Competition and Innovation Act (BPCIA)
Patent rights play an important role in the development and pricing of pharmaceuticals, including biological products (biologi . . .
Here are excerpts:
* * *
Pharmaceutical Patent Disputes: Biosimilar Entry Under the Biologics Price Competition and Innovation Act (BPCIA)
Patent rights play an important role in the development and pricing of pharmaceuticals, including biological products (biologi . . .